Pharmacodynamic Study of BKM120 in Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: BKM120
Sponsor: Sofia Perea, Director Clinical Trials Unit.
Collaborators: Novartis